A phase 2, randomized study of SB‐485232, rhIL‐18, in patients with previously untreated metastatic melanoma - Concepedia

Concepedia

Publication | Closed Access

A phase 2, randomized study of SB‐485232, rhIL‐18, in patients with previously untreated metastatic melanoma

120

Citations

32

References

2009

Year

Ahmad A. Tarhini, Michael Millward, Paul N. Mainwaring, Richard Kefford, T. Logan, Anna C. Pavlick, Steven J. Kathman, Kevin Laubscher, Mohammed M. Dar, John M. Kirkwood

Abstract

rIL-18 as tested in this trial was well tolerated, but had limited activity as a single agent in patients with metastatic melanoma.

References

	Year	Citations

Page 1